Cargando…

Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast

Ductal carcinoma in situ (DCIS) of the breast is able to induce stromal changes, which likely reflect the crosstalk between DCIS and its microenvironment. These changes harbor prognostic information, although the interobserver variability of scoring stromal changes is moderate. A more robust evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agahozo, Marie Colombe, van Bockstal, Mieke, Westenend, Pieter J., Galant, Christine, Lambein, Kathleen, Reisenbichler, Emily, Sinke, Renata, Wong, Serena, van Deurzen, Carolien H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858280/ https://www.ncbi.nlm.nih.gov/pubmed/35076865 http://dx.doi.org/10.1007/s10911-021-09504-4

Ejemplares similares

A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
por: Van Bockstal, Mieke R., et al.
Publicado: (2019)

Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells
por: Agahozo, Marie Colombe, et al.
Publicado: (2021)

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
por: Sieuwerts, Anieta M., et al.
Publicado: (2019)

Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
por: Van Bockstal, Mieke R., et al.
Publicado: (2020)

Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study
por: Van Bockstal, Mieke R., et al.
Publicado: (2021)

RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Meurs, Claudia J C, et al.
Publicado: (2020)

Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Loss of Y-Chromosome during Male Breast Carcinogenesis
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

Carcinoma in situ to invasive breast cancer
por: van Deurzen, Carolien H.M., et al.
Publicado: (2015)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023)

Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
por: Doebar, S. C., et al.
Publicado: (2018)

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
por: Meurs, Claudia J. C., et al.
Publicado: (2018)

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion
por: Van Bockstal, Mieke, et al.
Publicado: (2014)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study
por: van Deurzen, Carolien H. M.
Publicado: (2016)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
por: Derouane, Françoise, et al.
Publicado: (2022)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Deciduosis of the appendix: a rare cause of acute abdomen during pregnancy (a case report)
por: Smits, Louis, et al.
Publicado: (2020)

Classification of ductal carcinoma in situ by gene expression profiling
por: Hannemann, Juliane, et al.
Publicado: (2006)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort
por: Akdeniz, Delal, et al.
Publicado: (2022)

Fibroblast-induced matrix remodeling paves the path for invasion
por: Van Bockstal, Mieke, et al.
Publicado: (2015)

Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
por: Luiten, Jacky D., et al.
Publicado: (2021)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
por: Toss, Michael S., et al.
Publicado: (2018)

In Situ Hydroxyapatite Synthesis Enhances Biocompatibility of PVA/HA Hydrogels
por: Chocholata, Petra, et al.
Publicado: (2021)

Effect of Nano-HA/Collagen Composite Hydrogels on Osteogenic Behavior of Mesenchymal Stromal Cells
por: Hayrapetyan, Astghik, et al.
Publicado: (2016)

Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
por: Van Bockstal, Mieke R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0f819m1f14vi8ph570ulah02aq